Proteomics analysis of fetal growth restriction and taurine‑treated fetal growth restriction rat brain tissue by 2D DIGE and MALDI‑TOF/TOF MS analysis

Liu,Haifeng; Wang,Yan; Liu,Jing; Fu,Wei

doi:10.3892/ijmm.2019.4182

Proteomics analysis of fetal growth restriction and taurine‑treated fetal growth restriction rat brain tissue by 2D DIGE and MALDI‑TOF/TOF MS analysis

Authors:
- Haifeng Liu
- Yan Wang
- Jing Liu
- Wei Fu
View Affiliations

Affiliations: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, NICU of Taian City Central Hospital, Taian, Shandong 271000, P.R. China, Department of Neonatology and NICU, Beijing Chaoyang District Maternal and Child Healthcare Hospital, Beijing 100101, P.R. China
Published online on: May 7, 2019 https://doi.org/10.3892/ijmm.2019.4182
Pages: 207-217
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Fetal growth restriction (FGR) is caused by placental insufficiency and can lead to short and long‑term neurodevelopmental delays. Taurine, one of the most abundant amino acids in the brain, is critical for the normal growth and development of the nervous system; however, the mechanistic role of taurine in neural growth and development remains unknown. The present study investigated the role of taurine in FGR. Specifically, we explored the proteomic profiles of fetal rats at 6 h postpartum by two‑dimensional difference gel electrophoresis combined with matrix assisted laser desorption ionization‑time‑of‑flight (TOF)/TOF tandem mass spectrometry; the findings were verified via reverse transcription‑quantitative polymerase chain reaction. A total of 31 differentially expressed protein spots were selected. Among these, 31 were matched, including dihydropyrimidinase‑related protein 2 and , CRK and peroxiredoxin 2. Functional analysis using the Gene Ontology database and Ingenuity Pathway Analysis demonstrated that the differentially expressed proteins were mainly associated with neuronal differentiation, ‘metabolic process’, ‘biological regulation’ and developmental processes. The present study identified several proteins that were differentially expressed in rats with FGR in the presence or absence of taurine administration. The results of the present study suggest a potential role for taurine in the treatment and prevention of FGR.

View Figures

View References

1	Giabicani E, Pham A, Brioude F, Mitanchez D and Netchine I: Diagnosis and management of postnatal fetal growth restriction. Best Pract Res Clin Endocrinol Metab. 32:523–534. 2018. View Article : Google Scholar : PubMed/NCBI
2	Liu J, Wang XF, Wang Y, Wang HW and Liu Y: The incidence rate, high-risk factors, and short- and long-term adverse outcomes of fetal growth restriction: A report from Mainland China. Medicine (Baltimore). 93:e2102014. View Article : Google Scholar
3	Longo S, Bollani L, Decembrino L, Di Comite A, Angelini M and Stronati M: Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med. 26:222–225. 2013. View Article : Google Scholar
4	Verschuren MT, Morton JS, Abdalvand A, Mansour Y, Rueda-Clausen CF, Compston CA, Luyckx V and Davidge ST: The effect of hypoxia-induced intrauterine growth restriction on renal artery function. J Dev Orig Health Dis. 3:333–341. 2012. View Article : Google Scholar : PubMed/NCBI
5	Iruretagoyena JI, Davis W, Bird C, Olsen J, Radue R, Teo Broman A, Kendziorski C, Splinter BonDurant S, Golos T, Bird I and Shah D: Differential changes in gene expression in human brain during late first trimester and early second trimester of pregnancy. Prenat Diagn. 34:431–437. 2014. View Article : Google Scholar : PubMed/NCBI
6	Samuelsen GB, Pakkenberg B, Bogdanović N, Gundersen HJ, Larsen JF, Graem N and Laursen H: Severe cell reduction in the future brain cortex in human growth-restricted fetuses and infants. Am J Obstet Gynecol. 197:56.e1–e7. 2007. View Article : Google Scholar
7	Tatli M, Guzel A, Kizil G, Kavak V, Yavuz M and Kizil M: Comparison of the effects of maternal protein malnutrition and intrauterine growth restriction on redox state of central nervous system in offspring rats. Brain Res. 1156:21–30. 2007. View Article : Google Scholar : PubMed/NCBI
8	Liu J, Liu L and Chen H: Antenatal taurine supplementation for improving brain ultrastructure in fetal rats with intrauterine growth restriction. Neuroscience. 181:265–270. 2011. View Article : Google Scholar : PubMed/NCBI
9	Cohen E, Wong FY, Wallace EM, Mockler JC, Odoi A, Hollis S, Horne RSC and Yiallourou SR: EEG power spectrum maturation in preterm fetal growth restricted infants. Brain Res. 1678:180–186. 2018. View Article : Google Scholar
10	Fu LC, Lv Y, Zhong Y, He Q, Liu X and Du LZ: Tyrosine phosphorylation of Kv1.5 is upregulated in intrauterine growth retardation rats with exaggerated pulmonary hypertension. Braz J Med Biol Res. 50:e62372017. View Article : Google Scholar : PubMed/NCBI
11	Baschat AA: Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol. 37:501–514. 2011. View Article : Google Scholar : PubMed/NCBI
12	Nardozza LM, Caetano AC, Zamarian AC, Mazzola JB, Silva CP, Marçal VM, Lobo TF, Peixoto AB and Araujo Júnior E: Fetal growth restriction: Current knowledge. Arch Gynecol Obstet. 295:1061–1077. 2017. View Article : Google Scholar : PubMed/NCBI
13	Albu AR, Horhoianu IA, Dumitrascu MC and Horhoianu V: Growth assessment in diagnosis of fetal growth restriction. Review. J Med Life. 7:150–154. 2014.PubMed/NCBI
14	Metges CC, Görs S, Lang IS, Hammon HM, Brüssow KP, Weitzel JM, Nürnberg G, Rehfeldt C and Otten W: Low and high dietary protein: Carbohydrate ratios during pregnancy affect materno-fetal glucose metabolism in pigs. J Nutr. 144:155–163. 2014. View Article : Google Scholar
15	Li S, Guan H, Qian Z, Sun Y, Gao C, Li G, Yang Y, Piao F and Hu S: Taurine inhibits 2,5-hexanedione-induced oxidative stress and mitochondria-dependent apoptosis in PC12 cells. Ind Health. 55:108–118. 2017. View Article : Google Scholar :
16	Ripps H and Shen W: Review: Taurine: A 'very essential' amino acid. Mol Vis. 18:2673–2686. 2012.
17	Liu J, Liu L, Wang XF, Teng HY and Yang N: Antenatal supplementation of taurine for protection of fetal rat brain with intrauterine growth restriction from injury by reducing neuronal apoptosis. Neuropediatrics. 43:258–263. 2012. View Article : Google Scholar : PubMed/NCBI
18	Liu J, Wang X, Liu Y, Yang N, Xu J and Ren X: Antenatal taurine reduces cerebral cell apoptosis in fetal rats with intrauterine growth restriction. Neural Regen Res. 8:2190–2197. 2013.
19	Jansson N, Pettersson J, Haafiz A, Ericsson A, Palmberg I, Tranberg M, Ganapathy V, Powell TL and Jansson T: Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J Physiol. 576:935–946. 2006.PubMed/NCBI
20	Zhou X, Wang P, Zhang YJ, Xu JJ, Zhang LM, Zhu L, Xu LP, Liu XM and Su PP: Comparative proteomic analysis of melanosis coli with colon cancer. Oncol Rep. 36:3700–3706. 2016. View Article : Google Scholar : PubMed/NCBI
21	Yan-Fang T, Zhi-Heng L, Li-Xiao X, Fang F, Jun L, Gang L, Lan C, Na-Na W, Xiao-Juan D, Li-Chao S, et al: Molecular mechanism of the cell death induced by the histone deacetylase pan inhibitor LBH589 (Panobinostat) in Wilms tumor cells. PLoS One. 10:e01265662015. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
23	Cruz-Lemini M, Crispi F, Van Mieghem T, Pedraza D, Cruz-Martínez R, Acosta-Rojas R, Figueras F, Parra-Cordero M, Deprest J and Gratacós E: Risk of perinatal death in early-onset intrauterine growth restriction according to gestational age and cardiovascular doppler indices: A multicenter study. Fetal Diagn Ther. 32:116–122. 2012. View Article : Google Scholar : PubMed/NCBI
24	Romo A, Carceller R and Tobajas J: Intrauterine growth retardation (IUGR): Epidemiology and etiology. Pediatr Endocrinol Rev. 6(Suppl 3): S332–S336. 2009.
25	Figueras F, Cruz-Martinez R, Sanz-Cortes M, Arranz A, Illa M, Botet F, Costas-Moragas C and Gratacos E: Neurobehavioral outcomes in preterm, growth-restricted infants with and without prenatal advanced signs of brain-sparing. Ultrasound Obstet Gynecol. 38:288–294. 2011. View Article : Google Scholar : PubMed/NCBI
26	Bassan H, Stolar O, Geva R, Eshel R, Fattal-Valevski A, Leitner Y, Waron M, Jaffa A and Harel S: Intrauterine growth-restricted neonates born at term or preterm: How different? Pediatr Neurol. 44:122–130. 2011. View Article : Google Scholar : PubMed/NCBI
27	Park SY, Jung WJ, Kang JS, Kim CM, Park G and Choi YW: Neuroprotective effects of α-iso-cubebene against glutamate-induced damage in the HT22 hippocampal neuronal cell line. Int J Mol Med. 35:525–532. 2015. View Article : Google Scholar
28	Kubo T, Hata K, Yamaguchi A and Yamashita T: Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration. Curr Pharm Des. 13:2493–2499. 2007. View Article : Google Scholar : PubMed/NCBI
29	Turck CW, Webhofer C, Nussbaumer M, Teplytska L, Chen A, Maccarrone G and Filiou MD: Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. Proteomics Clin Appl. 10:1269–1272. 2016. View Article : Google Scholar : PubMed/NCBI
30	Tan F, Wahdan-Alaswad R, Yan S, Thiele CJ and Li Z: Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma. Cancer Sci. 104:1586–1592. 2013. View Article : Google Scholar : PubMed/NCBI
31	Arimura N and Kaibuchi K: Neuronal polarity: From extracellular signals to intracellular mechanisms. Nat Rev Neurosci. 8:194–205. 2007. View Article : Google Scholar : PubMed/NCBI
32	Inatome R, Tsujimura T, Hitomi T, Mitsui N, Hermann P, Kuroda S, Yamamura H and Yanagi S: Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. J Biol Chem. 275:27291–27302. 2000.PubMed/NCBI
33	Eaton BA, Fetter RD and Davis GW: Dynactin is necessary for synapse stabilization. Neuron. 34:729–741. 2002. View Article : Google Scholar : PubMed/NCBI
34	Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, et al: Mutant dynactin in motor neuron disease. Nat Genet. 33:455–456. 2003. View Article : Google Scholar : PubMed/NCBI
35	Lorenzo DN, Badea A, Davis J, Hostettler J, He J, Zhong G, Zhuang X and Bennett V: A PIK3C3-Ankyrin-B-Dynactin pathway promotes axonal growth and multiorganelle transport. J Cell Biol. 207:735–752. 2014. View Article : Google Scholar : PubMed/NCBI
36	Hempstead BL, Birge RB, Fajardo JE, Glassman R, Mahadeo D, Kraemer R and Hanafusa H: Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways. Mol Cell Biol. 14:1964–1971. 1994. View Article : Google Scholar : PubMed/NCBI
37	Matsuda M, Hashimoto Y, Muroya K, Hasegawa H, Kurata T, Tanaka S, Nakamura S and Hattori S: CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol Cell Biol. 14:5495–5500. 1994. View Article : Google Scholar : PubMed/NCBI
38	Birge RB, Fajardo JE, Mayer BJ and Hanafusa H: Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro. J Biol Chem. 267:10588–10595. 1992.PubMed/NCBI
39	Kowara R, Moraleja KL and Chakravarthy B: Involvement of nitric oxide synthase and ROS-mediated activation of L-type voltage-gated Ca²⁺ channels in NMDA-induced DPYSL3 degradation. Brain Res. 1119:40–49. 2006. View Article : Google Scholar : PubMed/NCBI
40	Kowara R, Kristoffer L and Chakravarthy B: Evidence that NMDA-induced DPYSL3 truncation involves ROS-mediated activation of nitric oxide synthase and L-type voltage-gated Ca²⁺ channels. Brain Res. 1119:40–49. 2006. View Article : Google Scholar : PubMed/NCBI
41	Kim YS, Kim EK, Jeon NJ, Ryu BI, Hwang JW, Choi EJ, Moon SH, Jeon BT and Park PJ: Antioxidant effect of taurine-rich paroctopus dofleini extracts through inhibiting ROS production against LPS-induced oxidative stress in vitro and in vivo model. Adv Exp Med Biol. 975(Pt 2): 1165–1177. 2017. View Article : Google Scholar : PubMed/NCBI